HYPERKALEMIA
Clinical trials for HYPERKALEMIA explained in plain language.
Never miss a new study
Get alerted when new HYPERKALEMIA trials appear
Sign up with your email to follow new studies for HYPERKALEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with dangerous potassium levels
Disease control Recruiting nowThis study tests a medicine called patiromer to see if it safely lowers high potassium levels in children under 12. High potassium can be harmful, especially for kids with kidney problems. The study will check how well the medicine works and monitor for side effects in 32 childre…
Matched conditions: HYPERKALEMIA
Phase: PHASE2 • Sponsor: Vifor Pharma, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Can adding urea to dialysis prevent dangerous brain swelling?
Disease control Recruiting nowThis study tests whether adding urea to the dialysis fluid can prevent dialysis disequilibrium syndrome — a set of neurological symptoms like headache, confusion, and seizures — in people with kidney failure who need urgent dialysis for severe electrolyte problems. Researchers wi…
Matched conditions: HYPERKALEMIA
Phase: PHASE1, PHASE2 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Fruit and veggie delivery could change kidney diet rules
Disease control Recruiting nowThis study tests whether people with chronic kidney disease can safely eat potassium-rich fruits and vegetables instead of following the usual low-potassium diet. Thirty participants will receive home-delivered groceries with either high- or low-potassium produce in a random orde…
Matched conditions: HYPERKALEMIA
Phase: NA • Sponsor: University of Manitoba • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Potassium drug may unlock better kidney and heart protection
Disease control Recruiting nowThis study tests whether patiromer, a drug that lowers potassium, allows people with moderate-to-severe chronic kidney disease to safely increase their dose of a common blood pressure medication (irbesartan). The goal is to see if this leads to better kidney protection and lower …
Matched conditions: HYPERKALEMIA
Phase: PHASE4 • Sponsor: University Medical Center Groningen • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New hope for high potassium: phase 3 drug trial launches
Disease control Recruiting nowThis study tests a new medicine called WS016 for people with high potassium levels (hyperkalemia). The trial has two parts: a short phase to quickly lower potassium, followed by a month-long phase to keep it in a safe range. About 420 adults with moderately high potassium will ta…
Matched conditions: HYPERKALEMIA
Phase: PHASE3 • Sponsor: Waterstone Pharmaceutical (Wuhan) Co., LTD. • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Smartphone ECG app could spot dangerous potassium levels in kidney patients
Diagnosis Recruiting nowThis study tests a smartphone app that uses ECG readings to detect dangerously high potassium levels in people with chronic kidney disease. About 50 adults will use the app during clinic visits or at home for up to four weeks. The goal is to see how accurate, easy-to-use, and rel…
Matched conditions: HYPERKALEMIA
Sponsor: AccurKardia, Inc. • Aim: Diagnosis
Last updated Jun 27, 2026 07:54 UTC
-
Brazilian study aims to unlock secrets of high potassium in heart and kidney patients
Knowledge-focused Recruiting nowThis study looks at data from over 6,000 Brazilian patients with heart failure, kidney disease, diabetes, or high blood pressure to understand how common high potassium levels (hyperkalemia) are and how doctors manage it. By analyzing medical records, researchers hope to identify…
Matched conditions: HYPERKALEMIA
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC